Pseudocin 196, a novel lantibiotic produced by Bifidobacterium pseudocatenulatum elicits antimicrobial activity against clinically relevant pathogens

Bacteriocins are broad or narrow-spectrum antimicrobial compounds that have received significant scientific attention due to their potential to treat infections caused by antibiotic-resistant pathogenic bacteria. The genome of Bifidobacterium pseudocatenulatum MM0196, an antimicrobial-producing, fec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut microbes 2024-12, Vol.16 (1), p.2387139
Hauptverfasser:	Sanchez-Gallardo, Rocio, O'Connor, Paula M., O'Neill, Ian J., McDonnell, Brian, Lee, Ciaran, Moore, Rebecca L., McAuliffe, Fionnuala M., Cotter, Paul D., van Sinderen, Douwe
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - metabolism Anti-Bacterial Agents - pharmacology antimicrobial peptide bacteriocin Bacteriocins - chemistry Bacteriocins - genetics Bacteriocins - metabolism Bacteriocins - pharmacology Bifidobacteria Bifidobacterium - drug effects Bifidobacterium - genetics Bifidobacterium - metabolism Clostridium - drug effects Clostridium - genetics Clostridium - metabolism Feces - microbiology Female Genome, Bacterial gut microbiota Humans Microbial Sensitivity Tests Multigene Family Pregnancy Probiotics - pharmacology Research Paper Streptococcus - drug effects Streptococcus - genetics Streptococcus - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!